Brian L. Batley

613 total citations
18 papers, 450 citations indexed

About

Brian L. Batley is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Brian L. Batley has authored 18 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Brian L. Batley's work include Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (5 papers) and Protein Tyrosine Phosphatases (4 papers). Brian L. Batley is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (5 papers) and Protein Tyrosine Phosphatases (4 papers). Brian L. Batley collaborates with scholars based in United States, United Kingdom and New Zealand. Brian L. Batley's co-authors include Robert L. Panek, Gina H. Lu, James M. Hamby, Tawny K. Dahring, Annette M. Doherty, Cleo J. C. Connolly, S. KLUTCHKO, Kathryn J. Brown, Joan A. Keiser and H. D. Hollis Showalter and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Brian L. Batley

18 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian L. Batley United States 11 311 150 87 41 32 18 450
James M. Hamby United States 17 542 1.7× 349 2.3× 121 1.4× 80 2.0× 50 1.6× 32 828
Susan E. Kephart United States 9 317 1.0× 193 1.3× 142 1.6× 50 1.2× 27 0.8× 14 571
Venkat R. Pallela United States 17 246 0.8× 278 1.9× 208 2.4× 26 0.6× 24 0.8× 25 738
Douglas W. Beight United States 10 392 1.3× 143 1.0× 210 2.4× 51 1.2× 39 1.2× 15 616
Andrea H. Epperly United States 9 371 1.2× 126 0.8× 248 2.9× 115 2.8× 31 1.0× 11 728
Yasushi Wada Japan 11 150 0.5× 112 0.7× 31 0.4× 58 1.4× 16 0.5× 45 502
Leonard C. Weir United States 7 232 0.7× 149 1.0× 122 1.4× 31 0.8× 35 1.1× 8 418
Joseph T. Repine United States 12 351 1.1× 250 1.7× 317 3.6× 30 0.7× 46 1.4× 18 778
Stephen C. Yabut United States 10 210 0.7× 205 1.4× 37 0.4× 25 0.6× 23 0.7× 14 417
Tawny K. Dahring United States 7 219 0.7× 93 0.6× 60 0.7× 32 0.8× 15 0.5× 7 318

Countries citing papers authored by Brian L. Batley

Since Specialization
Citations

This map shows the geographic impact of Brian L. Batley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian L. Batley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian L. Batley more than expected).

Fields of papers citing papers by Brian L. Batley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian L. Batley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian L. Batley. The network helps show where Brian L. Batley may publish in the future.

Co-authorship network of co-authors of Brian L. Batley

This figure shows the co-authorship network connecting the top 25 collaborators of Brian L. Batley. A scholar is included among the top collaborators of Brian L. Batley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian L. Batley. Brian L. Batley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schroeder, Mel C., James M. Hamby, Cleo J. C. Connolly, et al.. (2001). Soluble 2-Substituted Aminopyrido[2,3-d]pyrimidin-7-yl Ureas. Structure−Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity. Journal of Medicinal Chemistry. 44(12). 1915–1926. 49 indexed citations
2.
Thompson, Andrew M., Gordon W. Rewcastle, Brian G. Hartl, et al.. (2000). Synthesis and Structure−Activity Relationships of 7-Substituted 3-(2,6-Dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as Selective Inhibitors of pp60c-src. Journal of Medicinal Chemistry. 43(16). 3134–3147. 30 indexed citations
3.
Palmer, Brian D., Alan J. Kraker, Brian G. Hartl, et al.. (1999). Structure−Activity Relationships for 5-Substituted 1-Phenylbenzimidazoles as Selective Inhibitors of the Platelet-Derived Growth Factor Receptor. Journal of Medicinal Chemistry. 42(13). 2373–2382. 38 indexed citations
4.
Panek, Robert L., Gina H. Lu, Tawny K. Dahring, et al.. (1998). In Vitro Biological Characterization and Antiangiogenic Effects of PD 166866, a Selective Inhibitor of the FGF-1 Receptor Tyrosine Kinase. Journal of Pharmacology and Experimental Therapeutics. 286(1). 569–577. 76 indexed citations
5.
Batley, Brian L., Annette M. Doherty, James M. Hamby, et al.. (1997). INHIBITION OF FGF-1 RECEPTOR TYROSINE KINASE ACTIVITY BY PD 161570, A NEW PROTEIN-TYROSINE KINASE INHIBITOR. Life Sciences. 62(2). 143–150. 20 indexed citations
6.
Batley, Brian L., et al.. (1997). Heat stress increases cardiac HSP72i but fails to reduce myocardial infarct size in rabbits 24 hours later. Basic Research in Cardiology. 92(5). 331–338. 11 indexed citations
7.
Panek, Robert L., Gina H. Lu, S. KLUTCHKO, et al.. (1997). In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 283(3). 1433–1444. 80 indexed citations
8.
Lu, Gina H., et al.. (1997). Inhibition of Growth Factor-Mediated Tyrosine Phosphorylation in Vascular Smooth Muscle by PD 089828, a New Synthetic Protein Tyrosine Kinase Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 281(3). 1446–1456. 23 indexed citations
9.
Guruprasad, Kunchur, et al.. (1995). Exploring the binding preferences/specificity in the active site of human cathepsin E. Proteins Structure Function and Bioinformatics. 22(2). 168–181. 23 indexed citations
10.
11.
Ryan, Michael J., Brian L. Batley, S. T. Rapundalo, et al.. (1994). Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.. Journal of Pharmacology and Experimental Therapeutics. 268(1). 372–379. 8 indexed citations
12.
Steinbaugh, Bruce A., Harriet W. Hamilton, William C. Patt, et al.. (1994). Tetrahydroisoquinoline as a phenylalanine replacement in renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 4(16). 2029–2034. 6 indexed citations
13.
Palmer, R. Kyle, et al.. (1993). Disparity Between Blood Pressure and PRA Inhibition After Administration of a Renin Inhibitor to Anesthetized Dogs: Methodological Considerations. Clinical and Experimental Hypertension. 15(4). 663–681. 2 indexed citations
14.
Rao, Chetana, John E. Kay, Brian L. Batley, et al.. (1993). Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation. Journal of Medicinal Chemistry. 36(18). 2614–2620. 16 indexed citations
15.
Plummer, Mark S., et al.. (1993). Peptidomimetic inhibitors of renin incorporating topographically modified isosteres spanning the P1(→ P3)-P1' sites. Bioorganic & Medicinal Chemistry Letters. 3(10). 2119–2124. 10 indexed citations
16.
Doherty, Annette M., Ila Sircar, John Quin, et al.. (1992). Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors. Journal of Medicinal Chemistry. 35(1). 2–14. 52 indexed citations
17.
18.
Rao, Chetana, Paula E. Scarborough, W. Todd Lowther, et al.. (1991). Structure-Function Database for Active Site Binding to the Aspartic Proteinases. Advances in experimental medicine and biology. 306. 143–147. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James M. Hamby Breakdown of academic impact, for papers by Susan E. Kephart Breakdown of academic impact, for papers by Venkat R. Pallela Breakdown of academic impact, for papers by Douglas W. Beight Breakdown of academic impact, for papers by Andrea H. Epperly Breakdown of academic impact, for papers by Yasushi Wada Breakdown of academic impact, for papers by Leonard C. Weir Breakdown of academic impact, for papers by Joseph T. Repine Breakdown of academic impact, for papers by Stephen C. Yabut Breakdown of academic impact, for papers by Tawny K. Dahring
Rankless by CCL
2026